Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Talamo Joseph
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wesolowski John M
Intensity Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-LFP Management, LLC(5.4%)
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wesolowski John M
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DUBIN THOMAS I H
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Director DUBIN THOMAS I H
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wesolowski John M
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Leahy Emer
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOLDBERG MARK A
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Donovan Daniel
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BENDER LEWIS H
Intensity Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lewis H. Bender(16.1%)
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Talamo Joseph
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Talamo Joseph
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wesolowski John M
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Wesolowski John M
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer BENDER LEWIS H
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Director GOLDBERG MARK A
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Leahy Emer
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Donovan Daniel
No Data
No Data